Key Points
- Aflac Director Joseph Moskowitz sold 600 shares for approximately $74,460 under a pre-arranged Rule 10b5-1 trading plan, reducing his holdings by 1.8% to 32,710 shares.
- Aflac’s latest quarterly results slightly missed earnings expectations, with EPS of $1.75 versus the $1.76 consensus, while revenue of $4.22 billion exceeded forecasts but declined 1% year over year.
- The company declared a quarterly dividend of $0.61 per share, equivalent to $2.44 annually and a 2.0% yield. Analysts maintain a consensus “Hold” rating with an average price target of $117.58.
Aflac Incorporated (NYSE:AFL - Get Free Report) Director Joseph Moskowitz sold 600 shares of the company's stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $124.10, for a total value of $74,460.00. Following the completion of the transaction, the director owned 32,710 shares in the company, valued at $4,059,311. This represents a 1.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Aflac Price Performance
AFL stock opened at $120.62 on Thursday. Aflac Incorporated has a 52-week low of $103.80 and a 52-week high of $130.22. The company has a quick ratio of 0.11, a current ratio of 0.12 and a debt-to-equity ratio of 0.29. The stock has a market cap of $60.47 billion, a price-to-earnings ratio of 12.93, a price-to-earnings-growth ratio of 1.95 and a beta of 0.60. The business has a fifty day moving average of $121.18 and a two-hundred day moving average of $115.68.
Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The financial services provider reported $1.75 earnings per share for the quarter, missing analysts' consensus estimates of $1.76 by ($0.01). The business had revenue of $4.22 billion for the quarter, compared to analysts' expectations of $4.11 billion. Aflac had a return on equity of 13.27% and a net margin of 26.91%.The business's revenue for the quarter was down 1.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.78 earnings per share. As a group, research analysts anticipate that Aflac Incorporated will post 7.05 earnings per share for the current year.
Aflac Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Wednesday, August 19th will be paid a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Wednesday, August 19th. Aflac's dividend payout ratio (DPR) is 26.15%.
Aflac News Summary
Here are the key news stories impacting Aflac this week:
- Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $125 from $120 while maintaining a “market perform” rating, indicating limited but improved upside potential. Benzinga analyst rating update
- Positive Sentiment: Accident and health insurers, including Aflac, could benefit from increased underwriting exposure and greater digitalization. However, rising medical costs and inflation may pressure pricing. Zacks accident and health insurers outlook
- Neutral Sentiment: Wells Fargo kept a “hold” rating and a $120 price target, citing Aflac’s solid sector positioning but modest growth prospects and questions around mergers-and-acquisitions capital allocation. Wells Fargo Aflac rating
- Neutral Sentiment: Director Joseph L. Moskowitz sold 600 shares worth approximately $74,460 under a pre-arranged Rule 10b5-1 trading plan. The sale reduced his position by 1.8%, making it a limited insider-selling signal. Aflac insider transaction filing
- Negative Sentiment: JPMorgan lowered its price target to $116 from $117 and retained a “neutral” rating, implying downside from the referenced trading level. JPMorgan analyst rating update
- Negative Sentiment: Dowling & Partners cut its fiscal 2026 earnings-per-share estimate to $7.00 from $7.05, adding pressure after Aflac’s latest quarter slightly missed consensus EPS expectations and revenue declined year over year. Aflac earnings information
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Quarry LP purchased a new position in shares of Aflac in the 4th quarter valued at about $25,000. Groupe la Francaise acquired a new stake in Aflac in the first quarter valued at approximately $25,000. Edmond DE Rothschild Holding S.A. purchased a new position in Aflac in the second quarter worth approximately $27,000. Whipplewood Advisors LLC purchased a new position in Aflac in the first quarter worth approximately $25,000. Finally, Nalls Sherbakoff Group LLC acquired a new position in Aflac during the 4th quarter worth approximately $29,000. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on AFL shares. Jefferies Financial Group restated a "hold" rating and issued a $108.00 price objective (up from $100.00) on shares of Aflac in a report on Friday, July 10th. TD Cowen reissued a "hold" rating and issued a $110.00 target price (up from $101.00) on shares of Aflac in a research report on Wednesday, July 22nd. Morgan Stanley upped their price target on Aflac from $120.00 to $125.00 and gave the stock an "equal weight" rating in a research note on Thursday, May 21st. Barclays restated an "underweight" rating and set a $99.00 price target (up from $98.00) on shares of Aflac in a research report on Friday, August 7th. Finally, Keefe, Bruyette & Woods lifted their price objective on Aflac from $120.00 to $125.00 and gave the company a "market perform" rating in a research note on Tuesday. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $117.58.
Get Our Latest Research Report on Aflac
About Aflac
(
Get Free Report)
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac's product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
